Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder
-
Published:2022-06
Issue:6
Volume:40
Page:272.e1-272.e9
-
ISSN:1078-1439
-
Container-title:Urologic Oncology: Seminars and Original Investigations
-
language:en
-
Short-container-title:Urologic Oncology: Seminars and Original Investigations
Author:
Softness KennethORCID,
Kaul Sumedh,
Fleishman AaronORCID,
Efstathiou JasonORCID,
Bellmunt JoaquimORCID,
Kim Simon P.,
Korets RuslanORCID,
Chang Peter,
Wagner Andrew,
Olumi Aria F.ORCID,
Gershman Boris
Reference22 articles.
1. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017
2. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology;Shabsigh;Eur Urol,2009
3. Selective bladder preservation by combination treatment of invasive bladder cancer;Kaufman;N Engl J Med,1993
4. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy oncology group protocols 8802, 8903, 9506, 9706, 9906, and 0233;Mak;J Clin Oncol,2014
5. Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy;Huddart;BJU Int,2017
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献